Sheridan F Bowers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sheridan F Bowers has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Crispin Mukerebe
Mwanza Intervention Trials Unit/National Institute for Medical Research , Mwanza
1 shared publication - Danielle de Jong
Department of Cell and Chemical Biology, Leiden University Medical Center, Netherlands
1 shared publication - Govert Jan van Dam
Department of Parasitology, Leiden University Medical Center, Leiden, the Netherlands
1 shared publication Humphrey D Mazigo
Department of Parasitology, Catholic University of Health and Allied Sciences , Mwanza
1 shared publicationJane K Maganga
Mwanza Intervention Trials Unit/National Institute for Medical Research , Mwanza
1 shared publication- Jennifer A. Downs
Center for Global Health, Weill Cornell Medicine , New York, New York
1 shared publication
Latest Publications
- Open Access
- 1 May 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
Association of Schistosoma haematobium Infection With Decreased Pregnancy: A Prospective Cohort Study
We quantified incident pregnancies among reproductive-aged women with and without Schistosoma haematobium infection. Among 245 women, 59 (24.1%) became pregnant during a median follow-up of 370 days. Women with S. haematobium infection had a 52% lower rate of pregnancy within the study period compared with uninfected women (hazard ratio = 0.48 [0.29–0.80], P = .005).
- 1 May 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
Open AccessAssociation of Schistosoma haematobium Infection With Decreased Pregnancy: A Prospective Cohort Study
We quantified incident pregnancies among reproductive-aged women with and without Schistosoma haematobium infection. Among 245 women, 59 (24.1%) became pregnant during a median follow-up of 370 days. Women with S. haematobium infection had a 52% lower rate of pregnancy within the study period compared with uninfected women (hazard ratio = 0.48 [0.29–0.80], P = .005).